Fundraising FoxAutonomus
2 known investors
Find your way into Autonomus
Sign up to see every warm intro you have to Autonomus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Autonomus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AutonomUS develops technology to automate and standardize image-guided interventional medical procedures, aiming to make specialist interventional expertise available across settings from ERs and outpatient clinics to operating rooms and battlefield care. The company originated from a Department of Defense–supported collaboration between Massachusetts General Hospital physicians and MIT Lincoln Laboratory scientists.
Founders & leadership
Board
Investors · 2
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase I | 2023 | $74.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Autonomus do?
- AutonomUS develops technology to automate and standardize image-guided interventional medical procedures, aiming to make specialist interventional expertise available across settings from ERs and outpatient clinics to operating rooms and battlefield care. The company originated from a Department of Defense–supported collaboration between Massachusetts General Hospital physicians and MIT Lincoln Laboratory scientists.
- Who founded Autonomus?
- Autonomus was founded by Anthony Samir.
- Who are Autonomus's investors?
- Autonomus's investors include SBXi, Service Provider Capital.